Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This agent at higher dose has the most effective data and safety profile for weight loss, coming close to the benefits of bariatric surgery
Blood Sugar and Diabetes Prevention Across the SURPASS trials in type 2 diabetes, tirzepatide lowered HbA1c by 1.87% to 2.58% over 40 to 52 weeks, consistently outperforming insulin glargine, insulin degludec, and semaglutide 1 mg
Last verified: March 2026 | Data accuracy confirmed by ChemVerify Editorial Team What Is Tirzepatide
Research shows that the placenta contains high concentrations of glutathione
Potentiation of glucose-induced insulin secretion by GIP is diminished in chronic hyperglycaemic states due at least in part to a decrease in the Gs subtype of the GIP receptor in pancreatic beta cells, and further reasons for concern over GIP as a treatment for type 2 diabetes are that it increases glucagon secretion and adipose deposition [49]
